GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SomnoMed Ltd (OTCPK:SOMNF) » Definitions » Debt-to-Revenue

SomnoMed (SomnoMed) Debt-to-Revenue : 0.21 (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is SomnoMed Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

SomnoMed's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $1.91 Mil. SomnoMed's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $10.50 Mil. SomnoMed's annualized Revenue for the quarter that ended in Dec. 2023 was $60.39 Mil. SomnoMed's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 0.21.


SomnoMed Debt-to-Revenue Historical Data

The historical data trend for SomnoMed's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SomnoMed Debt-to-Revenue Chart

SomnoMed Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.06 0.27 0.14 0.17 0.28

SomnoMed Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.16 0.29 0.27 0.21

Competitive Comparison of SomnoMed's Debt-to-Revenue

For the Medical Devices subindustry, SomnoMed's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SomnoMed's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SomnoMed's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where SomnoMed's Debt-to-Revenue falls into.



SomnoMed Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

SomnoMed's Debt-to-Revenue for the fiscal year that ended in Jun. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(1.724 + 14.054) / 56.118
=0.28

SomnoMed's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(1.908 + 10.5) / 60.394
=0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Dec. 2023) Revenue data.


SomnoMed Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of SomnoMed's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


SomnoMed (SomnoMed) Business Description

Traded in Other Exchanges
Address
20 Clarke Street, Level 3, Crows Nest, Sydney, NSW, AUS, 2065
SomnoMed Ltd produces and sells oral treatment of sleep-related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep-disordered breathing relieving conditions. Its products include SomnoDent, Som Tabs, Som Morning Repositioner and others. Its geographical segments include North America, Europe, and Asia-Pacific. Business operations consist of the production and sale of products treating sleep-disordered breathing, which is the only reportable segment. Substantial revenue is realized from the European region.

SomnoMed (SomnoMed) Headlines

From GuruFocus

SomnoMed posts record Q4 and delivers on FY22 revenue guidance

By PRNewswire PRNewswire 07-26-2022

SomnoMed's North America Q1 revenue growth leads the way

By PRNewswire PRNewswire 10-28-2022